Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Lymphocytic Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm
Lymphocytic Neoplasm

Cancer Family

Lymphocytic Neoplasm

CI-CAN-00000223Explore in graph →

HematologicNon-malignant3,036 active trials72 approved drugs345 evidence items

NCIt: C7065

Overview
Statistics
Survival
Genomics38
Variants & evidence345
Drugs51
Trials12949
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (380)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 226–250 of 380 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.
· Lancet Haematol · 2021 · PMID 33357483 · validated civic_curation pubmed
Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan.
· Cancer Sci · 2021 · PMID 34159682 · validated civic_curation pubmed
EZH2 mutations are frequent and represent an early event in follicular lymphoma.
· Blood · 2013 · PMID 24052547 · validated civic_curation pubmed
PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.
· Blood · 2019 · PMID 30510083 · validated civic_curation pubmed
The t(1;19)(q23;p13) results in consistent fusion of E2A and PBX1 coding sequences in acute lymphoblastic leukemias.
· Blood · 1991 · PMID 1671560 · validated civic_curation pubmed
Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.
· J Clin Oncol · 1994 · PMID 7989935 · validated civic_curation pubmed
Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
· Leuk Lymphoma · 1999 · PMID 10194126 · validated

Showing 226–250 of 380 publications

← Previous
1
…
9
10
11
…
16
Next →

civic_curation

Translocation (9;22) is associated with extremely poor prognosis in intensively treated children with acute lymphoblastic leukemia.

· Blood · 1991 · PMID 1991160 · validated civic_curation pubmed

The genomic landscape of pediatric acute lymphoblastic leukemia.

· Nat Genet · 2022 · PMID 36050548 · validated civic_curation pubmed

Recurrent DUX4 fusions in B cell acute lymphoblastic leukemia of adolescents and young adults.

· Nat Genet · 2016 · PMID 27019113 · validated civic_curation pubmed

Deregulation of DUX4 and ERG in acute lymphoblastic leukemia.

· Nat Genet · 2016 · PMID 27776115 · validated civic_curation pubmed

Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia.

· Nat Commun · 2016 · PMID 27265895 · validated civic_curation pubmed

Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.

· Blood · 2011 · PMID 21487109 · validated civic_curation pubmed

Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.

· Blood · 2020 · PMID 31738823 · validated civic_curation pubmed

Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

· Cancer Cell · 2012 · PMID 22897847 · validated civic_curation pubmed

Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Münster Study Group.

· Blood · 1997 · PMID 9226156 · validated civic_curation pubmed

The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion.

· Blood · 1995 · PMID 7780150 · validated civic_curation pubmed

TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

· Leukemia · 1995 · PMID 8609706 · validated civic_curation pubmed

B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease.

· Mod Pathol · 2014 · PMID 24030742 · validated civic_curation pubmed

Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.

· Cancer Cell · 2016 · PMID 26859458 · validated civic_curation pubmed

The MLL recombinome of acute leukemias in 2017.

· Leukemia · 2018 · PMID 28701730 · validated civic_curation pubmed

Multilineage involvement in KMT2A-rearranged B acute lymphoblastic leukaemia: cell-of-origin, biology, and clinical implications.

· Histopathology · 2024 · PMID 38686611 · validated civic_curation pubmed

PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome.

· Leukemia · 2025 · PMID 39702796 · validated civic_curation pubmed

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

· Proc Natl Acad Sci U S A · 2008 · PMID 18765795 · validated civic_curation pubmed

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.

· Nature · 2011 · PMID 21796119 · validated cbioportal_study pubmed